Affiliations 

  • 1 School of Physics, University of Western Australia, Australia; Faculty of Health Sciences, National University of Malaysia, Bangi, Malaysia. Electronic address: [email protected]
  • 2 School of Physics, University of Western Australia, Australia; Department of Radiation Oncology, Sir Charles Gairdner Hospital, Australia
  • 3 Institute for Health Research, University of Notre Dame, Fremantle, Australia
  • 4 Department of Physical Sciences, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Australia
  • 5 Department of Radiation Oncology, Sir Charles Gairdner Hospital, Australia
  • 6 Department of Radiation Oncology, Sir Charles Gairdner Hospital, Australia; School of Surgery, University of Western Australia, Australia
  • 7 School of Medicine and Public Health, University of Newcastle, Australia
Radiother Oncol, 2015 Jul;116(1):112-8.
PMID: 26163088 DOI: 10.1016/j.radonc.2015.06.011

Abstract

To identify dosimetry, clinical factors and medication intake impacting urinary symptoms after prostate radiotherapy.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Similar publications